Alphatec Holdings, Inc. (ATEC) Stock Price

ATECStock

$9.44−41.11%52W

Market Cap$1.46B

P/E—

PEG Ratio0.48

Div yield—

Beta0.80

ATEC Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-44.16%

Price vs S&P 500 (4W)-8.54%

PEG Ratio0.48

VGM Score54.03

P/CF (Annual)33.29x

Book Value / Share (Quarterly)$0.07

P/TBV (Annual)63.76x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)29.62%

Cash Flow / Share (Quarterly)$-0.04

Price vs S&P 500 (YTD)-67.95%

Gross Margin (TTM)70.84%

Net Profit Margin (TTM)-13.50%

EPS (TTM)$-0.72

10-Day Avg Trading Volume1.48M

EPS Excl Extra (TTM)$-0.72

Revenue Growth (5Y)39.45%

EPS (Annual)$-0.96

ROI (Annual)-23.81%

Gross Margin (Annual)69.60%

Net Profit Margin (5Y Avg)-37.33%

Cash / Share (Quarterly)$0.77

Revenue Growth QoQ (YoY)15.07%

ROA (Last FY)-18.12%

Revenue Growth TTM (YoY)19.47%

EBITD / Share (TTM)$-0.30

ROE (5Y Avg)-498.29%

Operating Margin (TTM)-7.50%

Cash Flow / Share (Annual)$-0.03

P/B Ratio130.56x

P/B Ratio (Quarterly)115.34x

Net Income / Employee (Annual)$-157,000

EV / Revenue (TTM)2.41x

Net Interest Coverage (TTM)-2.17x

ROA (TTM)-13.88%

EV / EBITDA (TTM)233.69x

EPS Incl Extra (Annual)$-0.96

Current Ratio (Annual)2.06x

Quick Ratio (Quarterly)0.99x

3-Month Avg Trading Volume3.09M

52-Week Price Return-41.11%

Revenue / Employee (TTM)$892,700

Tangible BV / Share (Quarterly)$0.18

P/S Ratio (Annual)1.97x

Asset Turnover (Annual)0.97x

52-Week High$23.29

Operating Margin (5Y Avg)-33.78%

EPS Excl Extra (Annual)$-0.96

CapEx CAGR (5Y)16.50%

Tangible BV CAGR (5Y)-35.23%

26-Week Price Return-32.23%

Quick Ratio (Annual)1.22x

13-Week Price Return19.65%

Total Debt / Equity (Annual)15.71x

Current Ratio (Quarterly)1.89x

Enterprise Value$1.96B

Revenue / Share Growth (5Y)18.68%

Asset Turnover (TTM)1.03x

Book Value / Share Growth (5Y)-26.19%

Revenue / Employee (Annual)$837,000

Inventory Turnover (Annual)1.35x

Pretax Margin (Annual)-18.77%

Cash / Share (Annual)$1.07

3-Month Return Std Dev53.47%

Gross Margin (5Y Avg)66.92%

Net Income / Employee (TTM)$-120,500

ROE (Last FY)-397.90%

Net Interest Coverage (Annual)-1.26x

EPS Basic Excl Extra (Annual)$-0.96

P/FCF (TTM)123.02x

Receivables Turnover (TTM)7.49x

Total Debt / Equity (Quarterly)49.92x

EPS Incl Extra (TTM)$-0.72

Receivables Turnover (Annual)7.86x

ROI (TTM)-18.52%

P/S Ratio (TTM)1.85x

Pretax Margin (5Y Avg)-37.33%

Revenue / Share (Annual)$5.09

Tangible BV / Share (Annual)$0.18

Forward P/E20.29x

Price vs S&P 500 (52W)-59.67%

Year-to-Date Return-55.13%

5-Day Price Return2.16%

EPS Normalized (Annual)$-0.96

ROA (5Y Avg)-23.32%

Net Profit Margin (Annual)-18.76%

Month-to-Date Return-0.84%

Cash Flow / Share (TTM)$-1.06

EBITD / Share (Annual)$-0.56

Operating Margin (Annual)-13.05%

LT Debt / Equity (Annual)13.92x

P/CF (TTM)26.64x

ROI (5Y Avg)-31.16%

LT Debt / Equity (Quarterly)44.28x

EPS Basic Excl Extra (TTM)$-0.72

P/TBV (Quarterly)63.76x

P/B Ratio (Annual)86.75x

Inventory Turnover (TTM)1.30x

Pretax Margin (TTM)-13.46%

Book Value / Share (Annual)$0.24

Price vs S&P 500 (13W)17.69%

Beta0.80x

P/FCF (Annual)333.90x

Revenue / Share (TTM)$5.21

ROE (TTM)-435.93%

52-Week Low$6.82

vGradeD

gGradeB

mGradeC

vgmGradeC

ATEC Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 4, 2026	$0.07	$0.07	+1.30%(+$0.00)
Q1 2026	May 5, 2026	-$0.00	$0.00	+100.00%(+$0.00)
Q4 2025	Feb 24, 2026	$0.04	$0.06	+44.93%(+$0.02)
Q3 2025	Oct 30, 2025	-$0.02	$0.03	+233.39%(+$0.05)
Q2 2025	Jul 31, 2025	-$0.04	$0.02	+148.00%(+$0.06)

ATEC Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.11

4.14

Industry Peers — Surgical & Medical Instruments(140)

Symbol	Value Score	Growth Score	Momentum Score	Price
ATECAlphatec Holdings, Inc.	D	B	C	$9.44
SYKStryker Corporation	C	B	C	$330.69
MMM3M Company	C	D	C	$174.34
BSXBoston Scientific Corp.	C	B	D	$46.84
BDXBecton, Dickinson and Co.	B	D	B	$189.52
MDLNMedline Inc. Class A common stock	C	D	C	$35.28
RMDResMed Inc.	C	B	B	$240.33
DXCMDexCom, Inc.	D	B	B	$90.82
WSTWest Pharmaceutical Services, Inc.	D	C	B	$337.47
SOLVSolventum Corporation	C	C	B	$91.12
BAXBaxter International Inc.	B	D	B	$26.13
PENPenumbra, Inc.	D	C	C	$321.68
GMEDGLOBUS MEDICAL INC	B	B	C	$82.97
GKOSGlaukos Corporation	F	A	A	$179.87
PODDInsulet Corporation	C	A	C	$145.13
TFXTeleflex Incorporated	B	F	B	$139.67
STVNStevanato Group S.p.A.	D	C	C	$21.03
MMEDMiniMed Group, Inc. Common Stock	—	—	A	$20.10
MMSIMerit Medical Systems Inc	C	B	B	$90.49
HAEHaemonetics Corporation	C	C	A	$103.96
ICUIICU Medical Inc	C	D	B	$175.10
HTFLHeartflow, Inc. Common Stock	—	A	B	$47.78
IRTCiRhythm Holdings, Inc. Common Stock	F	A	C	$120.25
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	$47.57
ATRCAtriCure, Inc.	D	B	B	$48.54
UFPTUFP Technologies Inc	C	B	B	$300.05
NVCRNovoCure Limited Ordinary Shares	D	C	B	$17.82
LMATLeMaitre Vascular, Inc.	C	B	C	$80.45
INSPInspire Medical Systems, Inc.	B	B	B	$61.44
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	$25.64
TNDMTandem Diabetes Care, Inc.	D	C	B	$21.43
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	A	$14.64
IARTIntegra LifeSciences Holdings	B	D	B	$16.89
AORTArtivion, Inc.	C	C	C	$26.77
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	$20.83
IRMDiRadimed Corporation	D	B	C	$87.07
BVSBioventus Inc. Class A Common Stock	B	C	A	$13.84
BBNXBeta Bionics, Inc. Common Stock	D	A	B	$19.72
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	$26.42
SIBNSI-BONE, Inc. Common Stock	D	B	B	$19.21
SSIISS Innovations International Inc. Common Stock	F	A	D	$3.48
MDXGMiMedx Group, Inc	C	D	C	$4.50
ANGOAngioDynamics, Inc.	C	D	A	$15.85
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	$23.65
BWAYBrainsway Ltd. American Depositary Shares	F	A	B	$14.30
DCTHDelcath Systems Inc	D	B	A	$16.34
CERSCerus Corp	D	C	B	$2.65
TCMDTactile Systems Technology, Inc.	B	B	C	$23.16
NPCENeuropace, Inc. Common Stock	D	C	B	$14.41
CLPTClearPoint Neuro, Inc. Common Stock	F	A	B	$15.55
SGHTSight Sciences, Inc. Common Stock	D	B	A	$8.55

About Alphatec Holdings, Inc.

Alphatec Holdings is a medical technology company that develops spine surgery solutions for treating degenerative disc disease, spinal trauma, and congenital deformities. The company offers a portfolio of implants and surgical instruments across multiple fusion approaches—including anterior cervical, lateral interbody, and posterior lumbar procedures—designed to decompress nerves, stabilize the spine, and restore proper alignment. Its diverse product platform addresses a large and growing market for spinal surgery treatments.